Hyperglycemia in children with meningococcal sepsis and septic shock: The relation between plasma levels of insulin and inflammatory mediators

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 10, 2006, Pages 3916-3921

  Van Waardenburg, Dick A ^a,c   Jansen, Tim C ^b   Vos, Gijs D ^a   Buurman, Wim A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; LEPTIN; PROTEIN INTERLEUKIN 1 RECEPTOR 2; PROTEIN TNF R55; PROTEIN TNF R75; SOMATOMEDIN C; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; INFANT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTENSIVE CARE UNIT; MALE; MENINGOCOCCEMIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK;

EID: 33749577543     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0525     Document Type: Article

References (36)

1. Carlson GL 2004 Hunterian lecture: insulin resistance in human sepsis: implications for the nutritional and metabolic care of the critically ill surgical patient. Ann R Coll Surg Engl 86:75-81
2. Wolfe R 1997 Substrate utilization/insulin resistance in sepsi/trauma. Balliere's Clin Endocrinol Metab 4:645-657
3. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A 1997 Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63:356-361
4. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
5. Capes SE, Hunt D, Malmberg K, Gerstein HC 2000 Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778
6. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L 1995 Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26:57-65
7. Faustino EV, Apkon M 2005 Persistent hyperglycemia in critically ill children. J Pediatr 146:30-34
8. Finney SJ, Zekveld C, Elia A, Evans TW 2003 Glucose control and mortality in critically ill patients. JAMA 290:2041-2047
9. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461
10. Mizock BA 2001 Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15:533-551
11. Virkamaki A, Yki-Jarvinen H 1994 Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134:2072-2078
12. Lang CH, Dobrescu C, Meszaros K 1990 Insulin-mediated glucose uptake by individual tissues during sepsis. Metabolism 39:1096-1107
13. Carey LC, Cloutier CT, Lowery BD 1971 Growth hormone and adrenal cortical response to shock and trauma in the human. Ann Surg 174:451-460
14. Clowes Jr GH, Martin H, Walji S, Hirsch E, Gazitua R, Goodfellow R 1978 Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am J Surg 135:577-583
15. Dahn MS, Lange MP, Mitchell RA, Lobdell K, Wilson RF 1987 Insulin production following injury and sepsis. J Trauma 27:1031-1038
16. Petit F, Bagby GJ, Lang CH 1995 Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. Am J Physiol 268:E219-E228
17. Roh MS, Moldawer LL, Ekman LG, Dinarello CA, Bistrian BR, Jeevanandam M, Brennan MF 1986 Stimulatory effect of interleukin-1 upon hepatic metabolism. Metabolism 35:419-424
18. Mehta VK, Hao W, Brooks-Worrell BM, Palmer JP 1994 Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208-214
19. Jafari HS, McCracken Jr GH 1992 Sepsis and septic shock: a review for clinicians. Pediatr Infect Dis J 11:739-748
20. Yeh TS, Pollack MM, Ruttimann UE, Holbrook PR, Fields AI 1984 Validation of a physiologic stability index for use in critically ill infants and children. Pediatr Res 18:445-451
21. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M 2001 Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51:540-544
22. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE 2002 Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982
23. Joosten KF, de Kleijn ED, Westerterp M, de Hoog M, Eijck FC, Hop WCJ, Voort EV, Hazelzet JA, Hokken-Koelega AC 2000 Endocrine and metabolic responses in children with meningoccocal sepsis: striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 85:3746-3753
24. Dahn MS, Jacobs LA, Smith S, Hans B, Lange MP, Mitchell RA, Kirkpatrick JR 1985 The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg 120:166-172
25. Campfield LA, Smith FJ 1983 Neural control of insulin secretion: interaction of norepinephrine and acetylcholine. Am J Physiol 244:R629-R634
26. Holst JJ, Gromada J 2004 Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 287:E199-E206
27. de Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelzet JA, Hop WC, Uitterlinden P, van Doorn J, Hokken-Koelega AC 2002 Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 87:3118-3124
28. Blanco-Quiros A, Casado-Flores J, Arranz E, Garrote JA, Asensio J, Perez A 2002 Influence of leptin levels and body weight in survival of children with sepsis. Acta Paediatr 91:626-631
29. Arnalich F, Lopez J, Codoceo R, Jimnez M, Madero R, Montiel C 1999 Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock. J Infect Dis 180:908-911
30. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP 1998 Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 83:280-283
31. Carlson GL, Saeed M, Little RA, Irving MH 1999 Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis. Am J Physiol 276:E658-E662
32. Sonnenberg GE, Krakower GR, Hoffmann RG, Maas DL, Hennes MM, Kissebah AH 2001 Plasma leptin concentrations during extended fasting and graded glucose infusions: relationships with changes in glucose, insulin, and FFA. J Clin Endocrinol Metab 86:4895-4900
33. van Deuren M, Frieling JT, van der Ven-Jongekrijg J, Neeleman C, Russel FG, van Lier HJ, Bartelink AK, van der Meer JW 1998 Plasma patterns of tumor necrosis factor-α (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange. Clin Infect Dis 26:918-923
34. van Deuren M, van der Ven-Jongekrijg J, Bartelink AK, van Dalen R, Sauerwein RW, van der Meer JW 1995 Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 172:433-439
35. van Deuren M, van der Ven-Jongekrijg J, Vannier E, van Dalen R, Pesman G, Bartelink AK, Dinarello CA, van der Meer JW 1997 The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 90:1101-1108
36. Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML 1990 Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 86:856-863